Half-year report · Q2
7733.TEDINET S100UNV8
Period2024-04-01 → 2024-09-30
Filed2024-11-08
StandardIFRS
ConsolidatedYes
Data checks10 of 10 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥474.0bn | 2024-04-01 → 2024-09-30 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥925.8bn | 2023-04-01 → 2024-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥431.6bn | 2023-04-01 → 2023-09-30 | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥70.5bn | 2024-04-01 → 2024-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥3.8bn | 2023-04-01 → 2023-09-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥68.8bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥43.6bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | −¥2.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥49.0bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥242.6bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥216.3bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥49.0bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥216.7bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss IFRS |
| Total assets | ¥1.37T | at 2024-09-30 | Cons. | Assets IFRS |
| Total assets | ¥1.53T | at 2024-03-31 | Cons. | Assets IFRS |
| Total assets | ¥1.62T | at 2023-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥663.6bn | at 2024-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥777.0bn | at 2024-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥703.1bn | at 2024-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥757.2bn | at 2024-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥827.5bn | at 2023-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥641.2bn | at 2023-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥703.1bn | at 2024-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥757.2bn | at 2024-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥827.5bn | at 2023-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥245.9bn | at 2024-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥340.9bn | at 2024-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥488.2bn | at 2023-09-30 | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥93.7bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥42.4bn | 2023-04-01 → 2024-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | −¥11.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥30.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | ¥360.0bn | 2023-04-01 → 2024-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | ¥412.7bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥156.7bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥276.0bn | 2023-04-01 → 2024-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥125.4bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥42.24 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥199.91 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥173.81 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥42.16 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥199.44 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥173.81 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 51.4% | at 2024-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 49.4% | at 2024-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 51.2% | at 2023-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 10
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | −¥387m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥18.5bn |
| jpcrp040300-q2r_E02272-000Endoscopic Solutionsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥62.6bn |
| jpcrp040300-q2r_E02272-000Therapeutic Solutionsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥26.8bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥89.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥9m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥18.6bn |
| jpcrp040300-q2r_E02272-000Endoscopic Solutionsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥50.9bn |
| jpcrp040300-q2r_E02272-000Therapeutic Solutionsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥28.5bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥22.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 683
| Item | Context | Value | Unit |
|---|---|---|---|
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYTDDuration | 19000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYTDDuration_jpcrp040300-q2r_E02272-000EndoscopicSolutionsReportableSegmentMember | 21438000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYTDDuration_jpcrp040300-q2r_E02272-000TherapeuticSolutionsReportableSegmentMember | 9176000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYTDDuration_ReportableSegmentsMember | 30614000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 79000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYTDDuration_ReconcilingItemsMember | 2289000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYTDDuration | 32982000000 | JPY |
| Impairment losses pl IFRS | CurrentYTDDuration_jpcrp040300-q2r_E02272-000EndoscopicSolutionsReportableSegmentMember | 807000000 | JPY |
| Impairment losses pl IFRS | CurrentYTDDuration_jpcrp040300-q2r_E02272-000TherapeuticSolutionsReportableSegmentMember | 455000000 | JPY |
| Impairment losses pl IFRS | CurrentYTDDuration_ReportableSegmentsMember | 1262000000 | JPY |
| Impairment losses pl IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Impairment losses pl IFRS | CurrentYTDDuration_ReconcilingItemsMember | 179000000 | JPY |
| Impairment losses pl IFRS | CurrentYTDDuration | 1441000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-11-08 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第157期(2025年３月期)中（自 2024年４月１日 至 2024年９月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)オリンパス株式会社 | |
| Company name in english cover page | FilingDateInstant | OLYMPUS CORPORATION | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)取締役 代表執行役 会長兼 ESG オフィサー 竹内 康雄 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都八王子市石川町2951番地 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)042-642-2111(代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)経理部門バイスプレジデント 青柳 隆之 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都八王子市石川町2951番地 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)042-642-2111(代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)IR部門バイスプレジデント 櫻井 隆明 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E02272 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 77330 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)オリンパス株式会社 | |
| Filer name in english | FilingDateInstant | OLYMPUS CORPORATION | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | IFRS | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2024-04-01 | |
| Current period end date | FilingDateInstant | 2024-09-30 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2025-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2023-04-01 | |
| Comparative period end date | FilingDateInstant | 2023-09-30 | |
| Previous fiscal year end date | FilingDateInstant | 2024-03-31 | |
| Next fiscal year start date | FilingDateInstant | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |